High Investigation of the Role of Magnesium Aluminometasilicate (Neusilin^Ò US2) as a Porous Carrier for Improving the Amorphous Drug Loading and Stability of Ezetimibe by Hot Melt Extrusion

Background/Objective: The objective of the current research is to investigate the role of Neusilin US2 as a porous carrier for improving the drug loading and stability of Ezetimibe (EZB) by hot melt extrusion (HME). Methods: The amorphous solid dispersions (ASDs) were developed from 10-40% of drug loading using Kollidon VA 64 (Copovidone) as a polymer matrix. The solid-state characterization of EZB was studied using differential scanning calorimetry (DSC), powder x-ray diffraction (PXRD), and Fourier transform infrared spectroscopy (FTIR). The formulation blends were characterized for flow properties, and CTC (compressibility, tabletability, compactibility) profile. The in-vitro drug release profiles were studied in 0.1N HCl (pH 1.2). Results: The incorporation of Neusilin US2 has facilitated the development of ASDs up to 40% of drug loading. The CTC profile has demonstrated superior tabletability for the ternary (EZB, copovidone and Neusilin) dispersions over binary dispersion (EZB and copovidone) formulations. The tablet formulations with binary (20%) and ternary (30% and 40%) dispersions have demonstrated complete dissolution of the drug in 30 minutes in 0.1N HCl (pH 1.2). The incorporation of copovidone has prevented the recrystallization of the drug in the solution state. Upon storage of formulations at accelerated conditions, the stability of ternary dispersion tablets was preserved attributing to the entrapment of the drug within Neusilin pores thereby inhibiting molecular mobility. Conclusion: Based on the observations, the current research concludes that it is feasible to incorporate Neusilin US2 to improve the drug loading and stability of ASD systems.